INS and type 2 diabetes mellitus: In vitro experiments in pancreatic β-cells demonstrated that the overexpression of miR-19a-3p enhanced cell proliferation and insulin secretion and inhibited apoptosis, supporting miR-19a-3p as a candidate for managing type 2 diabetes [26].